Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Prepaid Assets (2016 - 2025)

Tg Therapeutics (TGTX) has 10 years of Prepaid Assets data on record, last reported at $57.6 million in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 266.38% year-over-year to $57.6 million; the TTM value through Dec 2025 reached $57.6 million, up 266.38%, while the annual FY2025 figure was $57.6 million, 266.38% up from the prior year.
  • Prepaid Assets reached $57.6 million in Q4 2025 per TGTX's latest filing, up from $55.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $57.6 million in Q4 2025 and bottomed at $2.5 million in Q3 2021.
  • Average Prepaid Assets over 5 years is $14.4 million, with a median of $7.6 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: plummeted 44.87% in 2021, then soared 308.97% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $2.9 million in 2021, then soared by 45.63% to $4.2 million in 2022, then skyrocketed by 126.64% to $9.5 million in 2023, then soared by 65.1% to $15.7 million in 2024, then soared by 266.38% to $57.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $57.6 million in Q4 2025, $55.8 million in Q3 2025, and $25.4 million in Q2 2025.